✓ Last verified: April 16, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: The only insurance-accepting Spravato (esketamine) provider in Corpus Christi — an integrative clinic combining family medicine, mental health care, and addiction medicine with in-network coverage across Aetna, Anthem BCBS, Cigna, OPTUM, and TRICARE.
| Review Scores | Only insurance-accepting Spravato provider in the Corpus Christi metro |
| Location | Corpus Christi, TX |
| Address | 400 Mann Street, Suite 107, Corpus Christi, TX 78401 |
| Phone | (361) 533-9911 |
| Website | ccintegrativeclinic.com |
| Treatments | Spravato (Esketamine) Nasal Spray, Family Medicine, Mental Health Care, Infusion Therapy, Addiction Medicine |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder, Anxious Depression, OCD, Smoking Addiction |
| Cost | Contact for pricing |
| Insurance | In-network with Aetna, Anthem Blue Cross/Blue Shield, Cigna, OPTUM, TRICARE, and other major carriers |
| Clinical Lead | Multi-clinician integrative medicine and mental health team |
HealingMaps Take: CC Integrative Clinic is the anchor of Corpus Christi’s interventional psychiatry market — and it’s essentially alone in that role. The Coastal Bend region has historically had minimal access to FDA-approved esketamine therapy, forcing patients with treatment-resistant depression to travel to San Antonio or Houston (both 2-3 hours away) or forgo the treatment entirely. CC Integrative’s decision to add Spravato to its integrative medicine practice closes that gap for roughly 450,000 Corpus Christi metro residents. The broader integrative medicine model is a meaningful clinical advantage: patients doing Spravato get their depression treated alongside family medicine, addiction medicine, and general mental health services under one clinical home, which matters because depression rarely exists in isolation from broader health issues. The insurance-in-network status across Aetna, Anthem BCBS, Cigna, OPTUM (UnitedHealthcare), and TRICARE is the practice’s single biggest differentiator — most Spravato providers nationally are cash-only, charging $800-$1,135 per session. Insurance coverage makes the 28-session-per-year Spravato protocol realistically affordable for working-class and middle-income South Texas patients. The downtown Mann Street location serves Corpus Christi proper and the broader Coastal Bend region including Portland, Robstown, Kingsville, and Rockport. For South Texas patients with treatment-resistant depression who need insurance-covered esketamine therapy, CC Integrative is the default — and effectively only — choice in the entire region.
Market Position: CC Integrative Clinic is a Spravato-certified clinic in the Christi metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. CC Integrative Clinic has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions CC Integrative Clinic treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — CC Integrative Clinic offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
CC Integrative Clinic treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Leave a Reply